Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs

Regulatory Peptides

Volumn 164, Issue 2-3, 2010, Pages 151-157

  Samarasinghe, Amali E ^a   Hoselton, Scott A ^a   Schuh, Jane M ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Asthma; Columnar epithelia; Immunohistochemistry; NEP; Smooth muscle; VIP

Indexed keywords

ALLERGEN; MEMBRANE METALLOENDOPEPTIDASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; ASPERGILLUS FUMIGATUS; COLUMNAR EPITHELIUM; CONTROLLED STUDY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE FIBER;

ALLERGENS; ANIMALS; ASPERGILLUS FUMIGATUS; BRONCHIAL HYPERREACTIVITY; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED C57BL; NEPRILYSIN; VASOACTIVE INTESTINAL PEPTIDE;

ASPERGILLUS; MURINAE; MUS;

EID: 77955847399     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.05.017     Document Type: Article

References (48)

1. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970, 169:1217-1218.
2. Groneberg D.A., Rabe K.F., Fischer A. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors. Eur J Pharmacol 2006, 533:182-194.
3. Dey R.D., Shannon W.A., Said S.I. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects. Cell Tissue Res 1981, 220:231-238.
4. Lundberg J.M., Hokfelt T., Kewenter J., Pettersson G., Ahlman H., Edin R., et al. Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology 1979, 77:468-471.
5. Palmer J.B., Cuss F.M., Barnes P.J. VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. J Appl Physiol 1986, 61:1322-1328.
6. Hamasaki Y., Saga T., Mojarad M., Said S.I. Vasoactive intestinal peptide counteracts leukotriene D4-induced contractions of guinea pig trachea, lung, and pulmonary artery. Trans Assoc Am Physicians 1983, 96:406-411.
7. Cutz E., Chan W., Track N.S., Goth A., Said S.I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 1978, 275:661-662.
8. Aliakbari J., Sreedharan S.P., Turck C.W., Goetzl E.J. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun 1987, 148:1440-1445.
9. Delgado M., Ganea D. Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?. J Immunol 2001, 166:2907-2912.
10. Maggi C.A., Giachetti A., Dey R.D., Said S.I. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev 1995, 75:277-322.
11. Pozo D., Delgado M. The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?. FASEB J 2004, 18:1325-1334.
12. Chanez P., Springall D., Vignola A.M., Moradoghi-Hattvani A., Polak J.M., Godard P., et al. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med 1998, 158:985-990.
13. Ollerenshaw S., Jarvis D., Woolcock A., Sullivan C., Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989, 320:1244-1248.
14. Szema A.M., Hamidi S.A., Lyubsky S., Dickman K.G., Mathew S., Abdel-Razek T., et al. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol 2006, 291:L880-L886.
15. Carstairs J.R., Barnes P.J. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. J Pharmacol Exp Ther 1986, 239:249-255.
16. Sharma R.K., Addis B.J., Jeffery P.K. The distribution and density of airway vasoactive intestinal polypeptide (VIP) binding sites in cystic fibrosis and asthma. Pulm Pharmacol 1995, 8:91-96.
17. Groneberg D.A., Hartmann P., Dinh Q.T., Fischer A. Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways. Lab Invest 2001, 81:749-755.
18. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994, 135:2662-2680.
19. Hogaboam C.M., Blease K., Mehrad B., Steinhauser M.L., Standiford T.J., Kunkel S.L., et al. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000, 156:723-732.
20. Said S.I. Vasoactive intestinal polypeptide (VIP) in asthma. Ann N Y Acad Sci 1991, 629:305-318.
21. Maruno K., Absood A., Said S.I. VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 1995, 268:L1047-L1051.
22. Sakai N., Tamaoki J., Kobayashi K., Isono K., T, K., Takeuchi S., et al. Vasoactive intestinal peptide stimulates ciliary motility in rabbit tracheal epithelium: modulation by neutral endopeptidase. Regul Pept 1991, 34:33-41.
23. Guan C.X., Zhang M., Qin X.Q., Cui Y.R., Luo Z.Q., Bai H.B., et al. Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells. Peptides 2006, 27:3107-3114.
24. Hokari R., Lee H., Crawley S.C., Yang S.C., Gum J.R., Miura S., et al. Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. Am J Physiol Gastrointest Liver Physiol 2005, 289:G949-G959.
25. Hollande E., Fanjul M., Claret S., Forgue-Lafitte M.E., Bara J. Effects of VIP on the regulation of mucin secretion in cultured human pancreatic cancer cells (Capan-1). In Vitro Cell Dev Biol Anim 1995, 31:227-233.
26. Dunzendorfer S., Kaser A., Meierhofer C., Tilg H., Wiedermann C.J. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001, 166:2167-2172.
27. Delgado M., Gonzalez-Rey E., Ganea D. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J 2004, 18:1453-1455.
28. Delgado M., Reduta A., Sharma V., Ganea D. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells. J Leukoc Biol 2004, 75:1122-1130.
29. Laitinen L.A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985, 131:599-606.
30. Litwin D.K., Wilson A.K., Said S.I. Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro. Regul Pept 1992, 40:63-74.
31. Delgado M., Munoz-Elias E.J., Gomariz R.P., Ganea D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNg synthesis by T cells. J Neuroimmunol 1999, 96:167-181.
32. Delgado M., Munoz-Elias E.J., Martinez C., Gomariz R.P., Ganea D. VIP and PACAP38 Modulate Cytokine and Nitric Oxide Production in Peritoneal Macrophages and Macrophage Cell Lines. Ann NY Acad Sci 1999, 897:401-414.
33. Delgado M., Munoz-Elias E.J., Gomariz R.P., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 1999, 162:1707-1716.
34. Lilly C.M., Martins M.A., Drazen J.M. Peptidase modulation of vasoactive intestinal peptide pulmonary relaxation in tracheal superfused guinea pig lungs. J Clin Invest 1993, 91:235-243.
35. Caughey G.H., Leidig F., Viro N.F., Nadel J.A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988, 244:133-137.
36. Goetzl E.J., Sreedharan S.P., Turck C.W., Bridenbaugh R., Malfroy B. Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11). Biochem Biophys Res Commun 1989, 158:850-854.
37. Gersch C., Dewald O., Zoerlein M., Michael L.H., Entman M.L., Frangogiannis N.G. Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol 2002, 118:41-49.
38. Sekizawa K., Tamaoki J., Graf P.D., Basbaum C.B., Borson D.B., Nadel J.A. Enkephalinase inhibitor potentiates mammalian tachykinin-induced contraction in ferret trachea. J Pharmacol Exp Ther 1987, 243:1211-1217.
39. King K.A., Hua J., Torday J.S., Drazen J.M., Graham S.A., Shipp M.A., et al. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest 1993, 91:1969-1973.
40. Borson D.B., Brokaw J.J., Sekizawa K., McDonald D.M., Nadel J.A. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 1989, 66:2653-2658.
41. Johnson A.R., Ashton J., Schulz W.W., Erdos E.G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985, 132:564-568.
42. Lundberg J.M., Saria A., Brodin E., Rosell S., Folkers K. A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A 1983, 80:1120-1124.
43. Di Maria G.U., Bellofiore S., Geppetti P. Regulation of airway neurogenic inflammation by neutral endopeptidase. Eur Respir J 1998, 12:1454-1462.
44. Umeno E., Nadel J.A., Huang H.T., McDonald D.M. Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat trachea. J Appl Physiol 1989, 66:2647-2652.
45. Connelly J.C., Skidgel R.A., Schulz W.W., Johnson A.R., Erdos E.G. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci U S A 1985, 82:8737-8741.
46. Dussaule J.C., Stefanski A., Bea M.L., Ronco P., Ardaillou R. Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex. Am J Physiol 1993, 264:F45-F52.
47. Baraniuk J.N., Ohkubo K., Kwon O.J., Mak J., Ali M., Davies R., et al. Localization of neutral endopeptidase (NEP) mRNA in human bronchi. Eur Respir J 1995, 8:1458-1464.
48. Erdos E.G., Skidgel R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989, 3:145-151.